why did fda ban tirzepatide Compounded Tirzepatide: Legal & Safe 2025 Friendly Reminder 💡 The only

If tirzepatide plateau persists beyond 12 weeks at an adequate dose, switching to semaglutide or exploring a dual compound can unlock the metabolic lever your body actually needs

According to the Phase 2 clinical data in November 2024, the average weight loss after 52 weeks was 20%, with efficacy comparable to that of tirzepatide and semaglutide, while achieving a lower frequency of administration

[DOI] [PubMed] [Google Scholar] 5

Have you just begun your path with Mounjaro (tirzepatide)

The company launched Mounjaro for type 2 diabetes in May 2022, followed by Zepbound for chronic weight management in November 2023